Skip to content

Efficacy and safety of the Dermatological Soap with ozonized sunflower oil (AGO) and Cream with AGO in patients with Acne.

Evaluation of the efficacy and safety of Dermatological Soap with ozonized sunflower oil and Cream with ozonized sunflower oil in patients with Acne. - AGO-CREAM-ACNE

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
RPCEC
Registry ID
RPCEC00000438
Enrollment
75
Registered
2024-04-15
Start date
2024-09-02
Completion date
Unknown
Last updated
2026-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acne

Interventions

Group 1 (Experimental): Dermatological soap with AGO. The treatment will be applied topicaccy for 60 days. Acne lesions will be washed three times a day: in the morning, in the afternon and at night b

Sponsors

National Center for Scientific Research
Lead Sponsor

Eligibility

Sex/Gender
All
Age
19 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients of both sexes with 19 years old or older, who have acne-type skin lesions, and who agree to participate in the study by signing an informed consent

Exclusion criteria

Exclusion criteria: Patients with: • Skin lesions with added infection • Known hypersensitivity to the products to be used. • Other skin lesions already diagnosed. • Severe or grade 3 acne with 21 and 50 inflammatory lesions on one half of the face, or where there are numerous (between 40 and 100) papules or pustules with deep, infiltrating nodular lesions, the areas of lesions extend beyond the face, to the back and back

Design outcomes

Primary

MeasureTime frame
Cure clinical (bsence of acneic skin lesions) or clinical improvement (significant reduction in acne skin lesions). Measurement time: At baseline and, 15, 30, 45 and 60 days of treatment.

Secondary

MeasureTime frame
1. EASI Scale (Eczema Area and Severity Index). Measurement time: At baseline and, 15, 30, 45 and 60 days of treatment. 2. Quality of Life (Dermatology Life Quality Index (DLQI)): Measurement time: At baseline and, 15, 30, 45 and 60 days of treatment.

Countries

Cuba

Contacts

Public ContactLidice Vazquez Sánchez

10 de Octubre Clinical Surgical Teaching Hospital

lidice.vazquez@infomed.sld.cu

Outcome results

None listed

Source: RPCEC (via WHO ICTRP) · Data processed: Aug 25, 2026